Genetic linkage and association of the growth hormone secretagogue receptor (Ghrelin receptor) gene in human obesity

被引:75
|
作者
Baessler, A
Hasinoff, MJ
Fischer, M
Reinhard, W
Sonnenberg, GE
Olivier, M
Erdmann, J
Schunkert, H
Doering, A
Jacob, HJ
Comuzzie, AG
Kissebah, AH
Kwitek, AE
机构
[1] Med Coll Wisconsin, Human & Mol Genet Ctr, Dept Physiol, Milwaukee, WI 53226 USA
[2] Univ Regensburg, Clin Internal Med 2, D-8400 Regensburg, Germany
[3] Univ Lubeck, Clin Internal Med 2, Lubeck, Germany
[4] GSF, Inst Epidemiol, Neuherberg, Germany
[5] SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78284 USA
关键词
D O I
10.2337/diabetes.54.1.259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The growth hormone secretagogue receptor (GHSR) (ghrelin receptor) plays an important role in the regulation of food intake and energy homeostasis. The GHSR gene lies on human chromosome 3q26 within a quantitative trait locus strongly linked to multiple phenotypes related to obesity and the metabolic syndrome. Because the biological function and location of the GHSR gene make it an excellent candidate gene, we tested the relation between common single nucleotide polymorphisms (SNPs) in the GHSR gene and human obesity. We performed a comprehensive analysis of SNPs, linkage disequilibrium (LD), and haplotype structure across the entire GHSR gene region (99.3 kb) in 178 pedigrees with multiple obese members (DNA of 1,095 Caucasians) and in an independent sample of the general population (MONICA Augsburg left ventricular hypertrophy substudy; DNA of 1,418 Caucasians). The LD analysis revealed a disequilibrium block consisting of five SNPs, consistent in both study cohorts. We found linkage among all five SNPs, their haplotypes, and BMI. Further, we found suggestive evidence for transmission disequilibrium for the minor SNP alleles (P < 0.05) and the two most common haplotypes with the obesity affection status ("susceptible" P = 0.025, "nonsusceptible" P = 0.045) in the family cohort using the familybased association test program. Replication of these findings in the general population resulted in stronger evidence for an association of the SNPs (best P = 0.00001) and haplotypes with the disease ("susceptible" P = 0.002, "nonsusceptible" P = 0.002). To our knowledge, these data are the first to demonstrate linkage and association of SNPs and haplotypes within the GHSR gene region and human obesity. This linkage, together with significant transmission disequilibrium in families and replication of this association in an independent population, provides evidence that common SNPs and haplotypes within the GHSR region are involved in the pathogenesis of human obesity.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 50 条
  • [21] Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas
    Kim, K
    Arai, K
    Sanno, N
    Osamura, RY
    Teramoto, A
    Shibasaki, T
    CLINICAL ENDOCRINOLOGY, 2001, 54 (06) : 759 - 768
  • [22] The growth hormone secretagogue receptor
    Korbonits, M
    Ciccarelli, E
    Ghigo, E
    Grossman, AB
    GROWTH HORMONE & IGF RESEARCH, 1999, 9 : 93 - 99
  • [23] The prospects of antagonizing the growth hormone secretagogue receptor to treat obesity
    Zhao, Hongyu
    Serby, Michael D.
    Liu, Bo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (09) : 989 - 998
  • [24] Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary
    Gaytan, F
    Barreiro, ML
    Chopin, LK
    Herington, AC
    Morales, C
    Pinilla, L
    Casanueva, FF
    Aguilar, E
    Diéguez, C
    Tena-Sempere, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02): : 879 - 887
  • [25] Molecular analysis of the human growth hormone secretagogue receptor
    Petersenn, S
    Penshorn, M
    Beil, FU
    Schulte, HM
    MEDIZINISCHE KLINIK, 1999, 94 (04) : 202 - 206
  • [26] Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor
    Witherington, Jason
    Abberley, Lee
    Bellenie, Benjamin R.
    Boatman, Rio
    Collis, Katharine
    Dean, David K.
    Gaiba, Alessandra
    King, N. Paul
    Shuker, Nicola
    Steadman, Jon G. A.
    Takle, Andrew K.
    Sanger, Gareth
    Butler, Sharon
    McKay, Fiona
    Muir, Alison
    Winborn, Kim
    Ward, Robert W.
    Heightman, Tom D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 684 - 687
  • [27] Expression of ghrelin or growth hormone secretagogue receptor in the brain of postpartum stress mice
    Xing, Jing-Wei
    Tian, Xin-Yun
    Chen, Man-Man
    Peng, Xiu-Hua
    Gao, Pengfei
    NEUROREPORT, 2021, 32 (08) : 678 - 685
  • [28] Purification and distribution of ghrelin: The natural endogenous ligand for the growth hormone secretagogue receptor
    Kojima, M
    Hosoda, H
    Kangawa, K
    HORMONE RESEARCH, 2001, 56 : 93 - 97
  • [29] Dynamics of the Ghrelin/Growth Hormone Secretagogue Receptor System in the Human Heart Before and After Cardiac Transplantation
    Sullivan, Rebecca
    Randhawa, Varinder K.
    Stokes, Anne
    Wu, Derek
    Lalonde, Tyler
    Kiaii, Bob
    Luyt, Leonard
    Wisenberg, Gerald
    Dhanvantari, Savita
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (04) : 748 - 762
  • [30] Regional Differences in the Ghrelin-Growth Hormone Secretagogue Receptor Signalling System in Human Heart Disease
    Sullivan, Rebecca
    Randhawa, Varinder K.
    Lalonde, Tyler
    Yu, Tina
    Kiaii, Bob
    Luyt, Leonard
    Wisenberg, Gerald
    Dhanvantari, Savita
    CJC OPEN, 2021, 3 (02) : 182 - 194